Osiris Therapeutics falls as Sanofi tiff continues

Shares of Osiris Therapeutics Inc. fell Monday after the company said it is still negotiating with French drugmaker Sanofi about the rights to its stem cell therapy Prochymal.

See the rest here:

Osiris Therapeutics falls as Sanofi tiff continues

Related Posts

Comments are closed.